Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction.

Alp E, Menevse S, Tulmac M, Yilmaz A, Yalcin R, Cengel A.

Genet Test Mol Biomarkers. 2011 Apr;15(4):193-202. doi: 10.1089/gtmb.2010.0113. Epub 2010 Dec 12.

PMID:
21142815
2.

Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study.

Alp E, Yilmaz A, Tulmac M, Ugras Dikmen A, Cengel A, Yalcin R, Menevse ES.

Kaohsiung J Med Sci. 2017 Feb;33(2):78-85. doi: 10.1016/j.kjms.2016.12.002. Epub 2017 Jan 12.

3.

Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population.

Alp E, Menevse S, Tulmac M, Kan D, Yalcin R, Erkan AF, Cengel A.

DNA Cell Biol. 2009 Jul;28(7):343-50. doi: 10.1089/dna.2009.0866.

PMID:
19435423
4.

Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.

Jguirim-Souissi I, Jelassi A, Slimani A, Addad F, Hassine M, Hamda KB, Najah M, Maatouk F, Rouis M, Slimane MN.

Coron Artery Dis. 2011;22(6):388-93. doi: 10.1097/MCA.0b013e3283478d40.

PMID:
21606841
5.

Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the Chinese Han population: a case-control study.

Wu HD, Bai X, Chen DM, Cao HY, Qin L.

Genet Test Mol Biomarkers. 2013 Sep;17(9):707-12. doi: 10.1089/gtmb.2013.0109. Epub 2013 Jul 2.

6.

An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.

Ashokkumar M, Anbarasan C, Saibabu R, Kuram S, Raman SC, Cherian KM.

Thromb Res. 2011 Oct;128(4):e49-53. doi: 10.1016/j.thromres.2011.05.026. Epub 2011 Jul 16.

PMID:
21762961
7.
8.

Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease.

Park KS, Min Y, Park SR, Kim EH, Lee DJ, Bang D, Lee ES.

Tissue Antigens. 2012 May;79(5):333-9. doi: 10.1111/j.1399-0039.2012.01863.x. Epub 2012 Mar 19.

PMID:
22428754
9.

Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.

Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I.

Coron Artery Dis. 2009 Sep;20(6):383-6. doi: 10.1097/MCA.0b013e32832fa9cf.

PMID:
19620856
10.

Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.

Diao LP, Ma H, Wei GC, Li T, Liu HS, Liu LH, Wu LL, Zhao GM, Gao YH.

Int J Cancer. 2012 Sep 1;131(5):1095-103. doi: 10.1002/ijc.26483. Epub 2011 Nov 28.

11.

The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population.

Tangurek B, Ozer N, Sayar N, Terzi S, Yilmaz H, Dayi SU, Ciloglu F, Aksu H, Asilturk R, Cagil A.

Heart Vessels. 2006 Sep;21(5):285-90. Epub 2006 Sep 29.

PMID:
17151815
12.

Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.

Pereza N, Ostojić S, Volk M, Kapović M, Peterlin B.

Reprod Biomed Online. 2012 May;24(5):567-75. doi: 10.1016/j.rbmo.2012.01.008. Epub 2012 Jan 24.

PMID:
22406112
13.

A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.

Vasků A, Goldbergová M, Izakovicová Hollá L, Sisková L, Groch L, Beránek M, Tschöplová S, Znojil V, Vácha J.

Matrix Biol. 2004 Jan;22(7):585-91.

PMID:
14996438
14.

Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.

Xu X, Wang L, Xu C, Zhang P, Yong F, Liu H, Wang J, Shi Y.

Coron Artery Dis. 2013 Jun;24(4):259-65. doi: 10.1097/MCA.0b013e32835ea3af.

PMID:
23377317
15.

Association of matrix metalloproteinases (MMP2, MMP7 and MMP9) genetic variants with left ventricular dysfunction in coronary artery disease patients.

Mishra A, Srivastava A, Mittal T, Garg N, Mittal B.

Clin Chim Acta. 2012 Oct 9;413(19-20):1668-74. doi: 10.1016/j.cca.2012.05.012. Epub 2012 Jun 1.

PMID:
22664146
16.

Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus.

Narne P, Ponnaluri KC, Singh S, Siraj M, Ishaq M.

J Diabetes Complications. 2013 May-Jun;27(3):255-61. doi: 10.1016/j.jdiacomp.2012.10.009. Epub 2012 Nov 20.

PMID:
23182401
17.

Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population.

Gao J, Shao Y, Lai W, Ren H, Xu D.

J Hum Genet. 2010 Oct;55(10):668-75. doi: 10.1038/jhg.2010.85. Epub 2010 Jul 29.

PMID:
20668462
18.

Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.

Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I.

Med Sci Monit. 2008 Oct;14(10):CR536-42.

PMID:
18830194
19.

Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients.

Aydoğan HY, Küçükhüseyin O, Tekeli A, Isbir T.

Genet Test Mol Biomarkers. 2012 Feb;16(2):134-7. doi: 10.1089/gtmb.2011.0077. Epub 2011 Aug 23.

PMID:
21861709
20.

Association of the gene polymorphisms of platelet glycoprotein Ia and IIb/IIIa with myocardial infarction and extent of coronary artery disease in the Korean population.

Park S, Park HY, Park C, Ko YG, Im EK, Jo I, Shin C, Lee JB, Shim WH, Cho SY, Jang Y.

Yonsei Med J. 2004 Jun 30;45(3):428-34.

Supplemental Content

Support Center